Dr Lisa McKerracher

Guest Contributor
December 21, 2007

Dr Lisa McKerracher has been appointed CEO of privately held Emerillon Therapeutics Inc. McKerracher joined the Montreal-based company last August to refocus its multiple technologies toward product development and clinical trials. She has been a professor at both McGill Univ and the Univ of Montreal and left academic research to become the founding scientist and chief scientific officer of BioAxone Therapeutic. Emerillon is a biotechnology firm focused on infectious disease and plans to move at least one compound toward clinical trials in the near term….

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies.
We use cookies to provide you with a great experience and to help our website run effectively
in accordance with our Privacy Policy and Terms of Service.